EyePoint Pharmaceuticals Inc. buy Chardan Capital
Start price
03.08.23
/
50%
€11.30
Target price
03.08.24
€20.11
Performance (%)
-37.17%
End price
04.08.24
€7.10
Summary
This prediction ended on 04.08.24 with a price of €7.10. The BUY prediction by Chardan_Capital for EyePoint Pharmaceuticals Inc. performed very badly with a performance of -37.17%. Chardan_Capital has a follow-up prediction for EyePoint Pharmaceuticals Inc. where he still thinks EyePoint Pharmaceuticals Inc. is a Buy. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
EyePoint Pharmaceuticals Inc. | -3.456% | -3.456% | -2.027% |
iShares Core DAX® | -1.471% | 1.895% | 25.178% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% |
Comments by Chardan_Capital for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $22.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat
In the thread Trading EyePoint Pharmaceuticals Inc.
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten
Current prediction by Chardan_Capital for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.92
07.05.24
07.05.24
€25.98
07.05.25
07.05.25
-25.01%
03.10.24
03.10.24
Stopped prediction by Chardan_Capital for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.25
28.06.24
28.06.24
€26.15
28.06.25
28.06.25
-9.87%
03.10.24
03.10.24
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.92
03.03.23
03.03.23
€19.79
03.03.24
03.03.24
797.26%
04.03.24
04.03.24